|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US20050137191A1
(en)
*
|
1996-06-04 |
2005-06-23 |
Thatcher Gregory R. |
Nitrate esters and their use for mitigating cellular damage
|
|
IT1288123B1
(it)
|
1996-09-04 |
1998-09-10 |
Nicox Sa |
Uso di nitroderivati per l'incontinenza urinaria
|
|
US6852739B1
(en)
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
|
IT1314184B1
(it)
*
|
1999-08-12 |
2002-12-06 |
Nicox Sa |
Composizioni farmaceutiche per la terapia di condizioni di stressossidativo
|
|
JP2003523958A
(ja)
|
1999-12-23 |
2003-08-12 |
ニトロメド インコーポレーテッド |
ニトロソ化およびニトロシル化されたシクロオキシゲナーゼ−２の阻害剤、組成物ならびに使用法
|
|
IT1317735B1
(it)
*
|
2000-01-26 |
2003-07-15 |
Nicox Sa |
Sali di agenti antimicrobici.
|
|
CA2410632A1
(en)
|
2000-06-22 |
2001-12-27 |
David S. Garvey |
Nitrosated and nitrosylated taxanes, compositions and methods of use
|
|
IT1319202B1
(it)
*
|
2000-10-12 |
2003-09-26 |
Nicox Sa |
Farmaci per le malattie a base infiammatoria.
|
|
CA2432642A1
(en)
|
2000-12-21 |
2002-08-08 |
Subhash P. Khanapure |
Substituted aryl compounds as novel cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
AU2008201838B2
(en)
*
|
2001-05-02 |
2010-07-29 |
Nicox S.A. |
Nitrosated and nitrosylated nebivolol and its metabolites, compositions and methods of use
|
|
ATE437637T1
(de)
|
2001-05-02 |
2009-08-15 |
Nitromed Inc |
Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
|
|
GB0111872D0
(en)
|
2001-05-15 |
2001-07-04 |
Northwick Park Inst For Medica |
Therapeutic agents and methods
|
|
SE0101702D0
(sv)
|
2001-05-15 |
2001-05-15 |
Ardenia Investments Ltd |
Novel potentiating compounds
|
|
ITMI20011307A1
(it)
*
|
2001-06-21 |
2002-12-21 |
Nicox Sa |
Farmaci per l'epilessia
|
|
ITMI20011308A1
(it)
|
2001-06-21 |
2002-12-21 |
Nicox Sa |
Farmaci per il dolore cronico
|
|
ITMI20011744A1
(it)
*
|
2001-08-09 |
2003-02-09 |
Nicox Sa |
Farmaci per le vasculopatie
|
|
EP2319518A1
(en)
|
2002-02-04 |
2011-05-11 |
ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. |
Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases
|
|
EP1497268A4
(en)
*
|
2002-04-05 |
2006-01-18 |
Nitromed Inc |
NITROGEN OXIDE DISPENSER, COMPOSITIONS AND METHOD OF USE
|
|
US7288535B2
(en)
|
2002-05-02 |
2007-10-30 |
Osteoscreen, Inc. |
Methods and compositions for stimulating bone growth using nitric oxide releasing bisphosphonate conjugates
|
|
US7220749B2
(en)
|
2002-06-11 |
2007-05-22 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
JP2005535642A
(ja)
|
2002-06-28 |
2005-11-24 |
ニトロメッド インコーポレーティッド |
オキシムおよび／またはヒドラゾンを含有するニトロソ化および／またはニトロシル化シクロオキシゲナーゼ−２選択的阻害剤、組成物、および使用方法
|
|
JP2005539089A
(ja)
*
|
2002-07-03 |
2005-12-22 |
ニトロメッド インコーポレーティッド |
ニトロソ化非ステロイド性抗炎症化合物、組成物および使用方法
|
|
CA2493156A1
(en)
|
2002-07-29 |
2004-02-05 |
Nitromed, Inc. |
Cyclooxygenase-2 selective inhibitors, compositions and methods of use
|
|
AU2003254282A1
(en)
|
2002-08-01 |
2004-02-23 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
|
ITMI20021861A1
(it)
*
|
2002-08-29 |
2004-02-29 |
Nicox Sa |
Procedimento di sintesi di nitrossialchilesteri di acidi carbossilici, intermedi impiegabili in detto procedimento e loro preparazione.
|
|
ITMI20022658A1
(it)
|
2002-12-17 |
2004-06-18 |
Nicox Sa |
Farmaci per il dolore cronico.
|
|
US7166638B2
(en)
|
2003-05-27 |
2007-01-23 |
Nicox S.A. |
Statin derivatives
|
|
US7169805B2
(en)
|
2003-05-28 |
2007-01-30 |
Nicox S.A. |
Captopril derivatives
|
|
WO2004110432A1
(en)
|
2003-06-19 |
2004-12-23 |
Nicox S.A. |
Enalapril-nitroxyderivatives derivatives and related compounds as ace inhibitors for the treatment of cardiovascular diseases
|
|
JP2007502831A
(ja)
*
|
2003-08-20 |
2007-02-15 |
ニトロメッド インコーポレーティッド |
ニトロソ化およびニトロシル化心血管化合物、組成物、ならびに使用方法
|
|
ATE399757T1
(de)
|
2003-11-20 |
2008-07-15 |
Nicox Sa |
Neues verfahren zur herstellung von nitrooxyderivaten von paracetamol
|
|
JP2007513113A
(ja)
*
|
2003-12-02 |
2007-05-24 |
ニコックス エス エイ |
抗高血圧薬剤のニトロオキシ誘導体
|
|
DK1691804T3
(da)
*
|
2003-12-02 |
2007-07-16 |
Nicox Sa |
Nitrooxydderivater af carvedilol og andre beta-blokkere som antihypertensive lægemidler
|
|
US20090131342A1
(en)
*
|
2004-01-22 |
2009-05-21 |
Nitromed, Inc. |
Nitrosated and/or nitrosylated compounds, compositions and methods of use
|
|
KR100503443B1
(ko)
*
|
2004-02-02 |
2005-07-22 |
한림제약(주) |
광학적으로 활성인 세티리진 또는 그의 염의 제조방법
|
|
WO2006008196A1
(en)
|
2004-07-20 |
2006-01-26 |
Nicox S.A. |
Process for preparing nitrooxy esters, nitrooxy thioesters, nitrooxy carbonates and nitrooxy thiocarbonates, intermediates useful in said process and preparation thereof
|
|
AU2005281359A1
(en)
|
2004-08-26 |
2006-03-16 |
Apparao Satyam |
Prodrugs and codrugs containing novel bio-cleavable disulfide linkers
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
KR101450653B1
(ko)
*
|
2006-07-18 |
2014-10-14 |
안티브 홀딩스 인크. |
비스테로이드 항염증제의 황화수소 유도체
|
|
TW200831079A
(en)
*
|
2006-12-13 |
2008-08-01 |
Merck & Co Inc |
Angiotensin II receptor antagonists
|
|
RU2340597C1
(ru)
*
|
2007-03-21 |
2008-12-10 |
Институт физиологически активных веществ Российской Академии наук |
Нитроксиалкиламинокислоты
|
|
US20080317673A1
(en)
*
|
2007-06-20 |
2008-12-25 |
Fatema Salem Al-Thallab |
Method for diagnosing and treating bronchial asthma
|
|
US20080319221A1
(en)
*
|
2007-06-22 |
2008-12-25 |
Bernd Junker |
Esters of Pentahydroxyhexylcarbamoyl Alkanoic Acids
|
|
WO2009007230A1
(en)
|
2007-07-09 |
2009-01-15 |
Nicox S.A. |
Use of nitric oxide releasing compounds in the treatment of chronic pain
|
|
EP2188245B1
(en)
|
2007-08-17 |
2013-11-06 |
Council of Scientific & Industrial Research |
Nitric oxide releasing derivatives of paracetamol
|
|
US7709634B2
(en)
*
|
2007-09-20 |
2010-05-04 |
Apotex Pharmachem Inc. |
Amorphous form of rifaximin and processes for its preparation
|
|
EP3090739A1
(en)
|
2008-01-04 |
2016-11-09 |
Schabar Research Associates LLC |
Compositions composed of naproxen sodium and nizatidine
|
|
RU2364394C1
(ru)
*
|
2008-03-19 |
2009-08-20 |
Михаил Владимирович Покровский |
Способ коррекции эндотелиальной дисфункции клопидогрелем при l-name индуцированном дефиците оксида азота
|
|
JP2011523941A
(ja)
*
|
2008-05-15 |
2011-08-25 |
メルク・シャープ・エンド・ドーム・コーポレイション |
アンギオテンシンｉｉ受容体アンタゴニスト
|
|
CA2728301A1
(en)
*
|
2008-07-03 |
2010-01-07 |
Osteogenex Inc. |
Vinpocetine and eburnamonine derivatives for promoting bone growth
|
|
MD4009C2
(ro)
*
|
2008-07-15 |
2010-08-31 |
Институт Химии Академии Наук Молдовы |
Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
|
|
HRP20140929T1
(hr)
|
2008-08-01 |
2014-12-05 |
Onconox Aps |
Antitumorska svojstva no-modificiranih inhibitora proteaze
|
|
WO2010108843A1
(en)
|
2009-03-27 |
2010-09-30 |
Nicox S.A. |
Use of nitrooxyderivative of paracetamol for the treatment of muscular dystrophies
|
|
FR2953145B1
(fr)
*
|
2009-11-30 |
2013-07-19 |
Inst Francais Du Petrole |
Solution absorbante contenant un inhibiteur de degradation derive de la pyrimidine ou de la triazine et procede d'absorption de composes acides contenus dans un effluent gazeux
|
|
CN101863900B
(zh)
*
|
2010-06-29 |
2012-07-25 |
天津药物研究院 |
一氧化氮供体型噻吩并吡啶衍生物、其制备方法和用途
|
|
CN102442908A
(zh)
*
|
2010-10-14 |
2012-05-09 |
天津药物研究院 |
制备萘普西诺的中间体及方法
|
|
JP5044059B2
(ja)
*
|
2010-11-02 |
2012-10-10 |
公益財団法人名古屋産業科学研究所 |
トランス−２−デセン酸誘導体及びこれを含有する医薬
|
|
JO3350B1
(ar)
|
2011-03-07 |
2019-03-13 |
Merck Sharp & Dohme |
مشتقات حلقية غير متجانسة محتوية على مجموعات أمينو أولية ومركبات داي أزينيومديولات
|
|
PT2699242T
(pt)
|
2011-04-19 |
2018-01-22 |
Alfama Inc |
Moléculas de libertação de monóxido de carbono e utilizações das mesmas
|
|
ES2628634T3
(es)
|
2011-07-21 |
2017-08-03 |
Alfama, Inc. |
Moléculas liberadoras de monóxido de carbono-rutenio y usos de las mismas
|
|
CN102557967A
(zh)
*
|
2011-12-28 |
2012-07-11 |
合肥科尚医药科技有限公司 |
一种盐酸氨溴索的制备方法
|
|
CA3042642A1
(en)
|
2013-08-12 |
2015-02-19 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded immediate release abuse deterrent pill
|
|
WO2015095391A1
(en)
|
2013-12-17 |
2015-06-25 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
US9492444B2
(en)
|
2013-12-17 |
2016-11-15 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extruded extended release abuse deterrent pill
|
|
DK3169315T3
(da)
|
2014-07-17 |
2020-08-10 |
Pharmaceutical Manufacturing Res Services In |
Væskefyldt doseringsform til forhindring af misbrug med øjeblikkelig frigivelse
|
|
EP3006453A1
(en)
|
2014-10-08 |
2016-04-13 |
Cosmo Technologies Ltd. |
17alpha-monoesters and 17alpha,21-diesters of cortexolone for use in the treatment of tumors
|
|
AU2015336065A1
(en)
|
2014-10-20 |
2017-05-04 |
Pharmaceutical Manufacturing Research Services, Inc. |
Extended release abuse deterrent liquid fill dosage form
|
|
US10881654B2
(en)
|
2015-04-24 |
2021-01-05 |
University Of Louisville Research Foundation, Inc. |
Selective PFKFB4 inhibitors for the treatment of cancer
|
|
US11420995B2
(en)
|
2017-03-03 |
2022-08-23 |
Synovo Gmbh |
Anti-infective and anti-inflammatory compounds
|
|
CA3073952A1
(en)
|
2017-08-31 |
2019-03-07 |
University Of Louisville Research Foundation, Inc. |
Quinoline derivative, compositions comprising this compound and uses thereof in the treatment of cancer
|
|
US10774046B2
(en)
|
2017-10-26 |
2020-09-15 |
University Of Louisville Research Foundation, Inc. |
Inhibitors for the treatment of cancer and related methods
|
|
RU2709067C1
(ru)
*
|
2018-07-23 |
2019-12-13 |
федеральное государственное бюджетное образовательное учреждение высшего образования "Тольяттинский государственный университет" |
Способ термосиловой обработки длинномерных осесимметричных деталей и устройство для его осуществления
|
|
US12514846B2
(en)
|
2020-07-15 |
2026-01-06 |
Schabar Research Associates Llc |
Unit oral dose compositions composed of ibuprofen or a pharmaceutically acceptable salt thereof and famotidine or a pharmaceutically acceptable salt thereof for the treatment of acute pain and the reduction of the severity and/or risk of heartburn and/or upset stomach
|
|
US11324727B2
(en)
|
2020-07-15 |
2022-05-10 |
Schabar Research Associates, Llc |
Unit oral dose compositions composed of naproxen sodium and famotidine for the treatment of acute pain and the reduction of the severity of heartburn and/or the risk of heartburn
|
|
JP2023534810A
(ja)
|
2020-07-15 |
2023-08-14 |
シャバー リサーチ アソシエイツ エルエルシー |
急性痛の処置並びに胸やけの重症度及び／又はリスクの低減のための、イブプロフェン及びファモチジンから構成される単位経口用量組成物
|
|
CN112316158B
(zh)
*
|
2020-11-19 |
2021-09-21 |
四川大学 |
一种利用超分子包合剂关闭胶原溶液中抗菌剂活性的方法
|
|
CN116270562B
(zh)
*
|
2022-03-18 |
2025-07-01 |
北京诺和德美医药科技有限公司 |
一种制备稳定的吸入用2-氨基-3,5-二溴苯甲胺衍生物溶液的方法
|